IDEX Business Summary

IDEX Corporation (NYSE: IEX) is a global industrial manufacturer specializing in highly engineered components and applied solutions for mission-critical applications. The company generates revenue primarily through the sale of specialized equipment across three core business segments: Health & Science Technologies (HST), which serves life sciences, semiconductor, and data center markets; Fluid & Metering Technologies (FMT), providing precision pumps and valves for municipal water and energy sectors; and Fire & Safety/Diversified Products (FSDP), which includes fire suppression and rescue tools. IDEX utilizes a disciplined "80/20" operating model to optimize its portfolio of over 50 decentralized businesses, focusing on high-margin niche markets. Its primary direct competitors include Dover Corporation, Parker Hannifin, Nordson, and AMETEK. Within this landscape, IDEX maintains a premium market position as a specialized leader in micro-precision technology and fluidics, often commanding higher margins than broader industrial conglomerates due to its focus on complex, low-volume, high-value solutions. IDEX was established in 1988 through a leveraged buyout of several industrial units from Houdaille Industries, orchestrated by Kohlberg Kravis Roberts & Co. (KKR) and led by inaugural CEO Donald N. Boyce. The current leadership team is headed by CEO and President Eric D. Ashleman, who assumed the role in December 2020 after serving as COO and having previously led the Gast Manufacturing unit. Joining him is Sean M. Gillen, who was appointed Senior Vice President and Chief Financial Officer in January 2026, bringing a pedigree from AAR Corp, USG Corporation, and Goldman Sachs. Other key executives include Lisa M. Anderson, who serves as General Counsel and Chief Administrative Officer, and Rahul Sharma, the Chief Information Officer. The company’s strategic direction is supported by a board that includes independent director Alejandro Quiroz Centeno and is characterized by a recent shift toward bolt-on acquisitions, such as the 2025 integration of Micro-LAM and Mott Corporation, to bolster its high-growth health and science platforms.